Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02998268
Title Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Pembrolizumab

Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.